SAN DIEGO, Jul 30, 2004 /PRNewswire-FirstCall via COMTEX/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD) announced today that it will present at the 24th Annual AdamsHarkness Summer Seminar on Thursday, August 5, 2004, at 4:00 pm EDT. ACADIA'spresentation will be given by Uli Hacksell, Ph.D., ACADIA's Chief ExecutiveOfficer, and will be webcast from the Marriott Long Wharf Hotel in Boston.
A live webcast of ACADIA's presentation will be accessible on thecompany's website, www.acadia-pharm.com under the investor relations section,and an archived recording will be available through August 19, 2004.
About ACADIA
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovativescience to fuel drug discovery and clinical development of novel treatmentsfor central nervous system disorders. ACADIA currently has five drug programsin clinical and preclinical development directed at large unmet medical needsand major commercial markets, including Parkinson's disease, schizophrenia,chronic pain, and glaucoma. Using its proprietary drug discovery platform,ACADIA has discovered all of the drug candidates in its product pipeline.ACADIA's headquarters and biological research facilities are located inSan Diego, California and its chemistry research facilities are located inCopenhagen, Denmark.
For further information please contact:
ACADIA Pharmaceuticals
Thomas H. Aasen, Vice President and Chief Financial Officer
+1 858-558-2871
ir@acadia-pharm.com